What Is Rapamycin? Benefits, Safety and Use in Dogs and Cats

We all want more healthy years with our pets. But dogs and cats age much faster than we do. Diseases linked to aging can also begin long before we notice any signs.

This is why many pet parents are asking about rapamycin.

Rapamycin, also called sirolimus, is a prescription drug that affects a cell pathway called mTOR. This pathway plays a major role in aging, inflammation, cell growth, and immune function.

At Helping Pets Live Longer, Dr. Kevin Toman has managed more than 600 dogs and almost 400 cats receiving rapamycin. His focus is not simply providing access to a pill. It is determining whether rapamycin fits into a safe, personalized medical strategy for each pet.

Rapamycin is not a miracle drug. It is one possible part of a complete longevity plan.

At Helping Pets Live Longer, Dr. Kevin Toman has managed more than 400 dogs receiving rapamycin. His goal is not simply to provide access to the medication. His goal is to decide whether it is right for each pet and then use it as safely as possible.

How can rapamycin help my pet?

Scientists are studying rapamycin for its possible benefits on:

• Aging
• Heart health
• Cancer
• Inflammation
• Immune aging
• Brain health
• Kidney disease
• Dental disease

Rapamycin is not a vitamin or supplement. It is a powerful prescription medication that should be used only with veterinary guidance.

How does rapamycin work?

Rapamycin blocks part of a cell pathway called the mechanistic target of rapamycin, or mTOR.

mTOR acts like a growth switch inside the body. It helps cells respond to food, energy, hormones, and other growth signals.

When mTOR activity is high, cells focus on growing and making new proteins. When mTOR activity is reduced, cells can shift more energy toward maintenance and repair.

Rapamycin may also support a natural cleanup process called autophagy. During autophagy, cells break down and recycle old or damaged parts.

This may help cells work better as the body ages.

Why are scientists studying rapamycin for longevity?

Rapamycin is one of the most studied longevity drugs in the world.

It has extended lifespan in several laboratory species, including mice. In one major study, rapamycin helped mice live longer even when treatment started later in life.

These results are exciting. But mice are not dogs or cats.

Scientists are now studying whether rapamycin can improve health and lifespan in companion dogs. The Dog Aging Project’s TRIAD trial is designed to answer some of these questions.

Until those results are complete, we cannot say that rapamycin has been proven to extend a dog’s life.

What we can say is that rapamycin has:

• Strong scientific support from laboratory studies
• A clear effect on a pathway linked to aging
• Promising early results in dogs and cats
• Growing veterinary safety experience
• Important questions that still need answers

What do studies show in dogs?

A small clinical study looked at low-dose rapamycin in 24 healthy, middle-aged dogs.

Half of the dogs received rapamycin. The other dogs received a placebo. Treatment continued for ten weeks.

Dogs receiving rapamycin showed improvement in certain measures of heart function. The researchers did not find major clinical side effects during the short study.

This was an encouraging result, but the study had limits:

• It included only 24 dogs.
• Treatment lasted only ten weeks.
• The dogs were generally healthy.
• The study did not measure lifespan.
• It did not prove long-term safety.

The study suggests that rapamycin deserves more research. It does not prove that rapamycin reverses heart disease or extends dogs’ lives.

What do studies show in cats?

The strongest evidence in pets involves cats with early hypertrophic cardiomyopathy, or HCM.

HCM causes the muscular wall of the heart to become too thick. Some cats remain stable for years. Others develop heart failure, blood clots, or sudden death.

The RAPACAT clinical trial studied a delayed-release form of rapamycin in cats with early HCM. Cats receiving the medication showed improvement in measurements of heart-wall thickness compared with cats receiving a placebo.

This research led to the conditional FDA approval of Felycin-CA1 for certain otherwise healthy cats with subclinical HCM.

Felycin is not appropriate for every cat with HCM. It has important safety rules, drug interactions, and monitoring needs. It is not intended for cats with heart failure, a history of blood clots, or certain other health problems.

The HCM study also does not prove that rapamycin extends cats’ lives or treats every age-related feline disease.  However, its safety makes a compelling use case.

What are the possible benefits of rapamycin?

Healthy aging

Rapamycin has extended lifespan by up to 14% in every mammal species studied to date. This makes it one of the most important drugs being studied in longevity medicine.

The real goal is not simply a longer life. It is a longer healthspan—more years in which your pet remains active, comfortable, alert, and engaged.

Heart health

A  dog study found improvement in certain measurements of heart function after short-term rapamycin treatment.

In cats, delayed-release rapamycin has stronger evidence for a specific condition called Hypertrophic Cardiomyopathy, or HCM.   This is a progressive and fatal disease that affects 1 out of every 6 cats worldwide.

These results are promising. However, rapamycin has not been proven to reverse every type of heart disease in dogs or cats.

Cancer biology

mTOR helps control cell growth. Cancer cells can use this pathway to grow and spread.

Rapamycin and related drugs may affect:

• Cancer-cell growth
• Blood supply to tumors
• Cancer-cell metabolism
• Abnormal cell division
• Programmed cancer-cell death

These effects may be useful in certain cancers. But rapamycin has not been proven to prevent cancer in healthy pets.

It should never replace proper cancer screening, surgery, chemotherapy, radiation, or care from a veterinary oncologist.

Inflammation and mobility

Aging is often linked to ongoing low-grade inflammation. Rapamycin may affect some of the pathways involved in this process.

Some HPLL pet parents report better activity, comfort, or engagement after their dogs begin rapamycin. These reports are encouraging, but they do not prove that rapamycin treats arthritis or chronic pain.

A complete mobility plan may also include:

• Weight control
• Regular exercise
• Rehabilitation
• Omega-3 fatty acids
• UC-II
• Prescription pain medications
• Disease-modifying arthritis treatments

Immune function

Rapamycin can affect the immune system in different ways.

High daily doses may suppress immune function. Lower, less frequent doses may have different effects on immune aging.

Rapamycin should not be described as a simple “immune booster.” A veterinarian should consider your pet’s vaccination schedule, infection risk, medications, and overall health.

Kidney health

Laboratory research suggests that mTOR is involved in kidney inflammation and scarring.

However, rapamycin has not been proven to slow chronic kidney disease in dogs or cats. In some situations, mTOR inhibitors can also contribute to protein loss in the urine.

Pets with kidney disease need careful testing and monitoring before and during treatment.

Dental health

Animal studies suggest that rapamycin may reduce inflammation in tissues around the teeth.

This research is interesting, but rapamycin cannot replace professional dental care. Pets still need oral examinations, dental X-rays, and treatment of painful dental disease.

Is rapamycin safe for dogs?

Low-dose, intermittent rapamycin appears to be very well tolerated by many carefully selected dogs.

In Dr. Kevin’s experience with more than 400 dogs, mild and temporary digestive upset has been the most common side effect, and that affects only 3-5% of patients.

This is HPLL’s real-world clinical experience. It is not the same as a controlled research study. Every dog can respond differently.

However, no prescription drug is risk-free.

Which pets may not be good candidates?

Rapamycin may not be right for pets with:

• An active infection
• Poorly controlled diabetes
• Serious liver disease
• Unexplained protein in the urine
• Severe intestinal disease
• Major immune problems
• An upcoming surgery or dental procedure
• Pregnancy or nursing
• Important drug interactions
• Missing medical records or baseline tests

A pet’s age alone should not decide whether rapamycin is appropriate.

What testing should be done?

Before starting rapamycin, a veterinarian may recommend:

• Complete blood count
• Blood chemistry panel
• Blood glucose
• Liver and kidney values
• Urinalysis
• Urine protein testing when needed
• Blood pressure
• Review of medications and supplements
• Other tests based on breed, age, and health history

Testing is often repeated after treatment begins. The timing depends on your pet’s health, dose, and treatment plan.

Monitoring is not an extra step. It is part of using rapamycin safely.

What is the correct rapamycin dose for dogs?

There is no single dose that is right for every dog.

Veterinarians often use rapamycin on an intermittent schedule instead of giving it every day. The correct amount and schedule depend on:

• Weight
• Age
• Breed
• Current health
• Kidney and liver function
• Other medications
• Treatment goals
• Rapamycin formulation
• Laboratory results
• Individual response

Pet parents should not calculate or change a rapamycin dose using general information found online.

How does rapamycin compare with acarbose and metformin?

Rapamycin is not the only prescription drug being studied for longevity.

Drug	Main action	What we currently know
Rapamycin	Reduces mTOR activity	Strong lifespan evidence in laboratory animals; dog studies are underway
Acarbose	Reduces the rise in blood sugar after meals	Extended lifespan in mice, especially males
Metformin	Improves glucose control and affects metabolic pathways	Widely studied, but longevity evidence remains mixed

 

These drugs work in different ways. They are not right for every pet, and combining medications does not guarantee a better result.

 

Frequently asked questions

Can rapamycin reverse aging?

No drug has been proven to reverse aging in dogs or cats.

Rapamycin affects pathways involved in aging and has extended lifespan in laboratory animals. Whether it extends lifespan in pet dogs and cats is still being studied.

Is rapamycin an immunosuppressant?

Yes, especially when used at higher daily doses.  

Lower, intermittent dosing may affect the immune system differently. Veterinary supervision is still essential.

Is rapamycin approved for dog longevity?

No. Rapamycin is not FDA-approved to extend dogs’ lives. Its use for canine longevity is off-label.

Felycin-CA1 has conditional FDA approval for a specific use in certain cats with early HCM. That approval does not apply to general longevity treatment.

Can rapamycin be given with other medications?

Sometimes, but important drug interactions are possible.

Your veterinarian should review all medications, supplements, and over-the-counter products before your pet begins treatment.

When should a dog start rapamycin?

There is no agreed-upon starting age.

A veterinarian should consider:

• Breed and body size
• Current health
• Family history
• Laboratory results
• Medications
• Age-related risks
• Treatment goals

The best decision is based on the whole dog—not age alone.

How long does a dog stay on rapamycin?

Rapamycin is usually considered a long-term strategy rather than a short treatment.

The decision to continue should depend on laboratory results, side effects, health changes, and ongoing veterinary review.

Is rapamycin right for your dog?

The most important question is not:

“Where can I buy rapamycin?”

The better question is:

“Does rapamycin belong in my dog’s longevity plan, and how can we use it safely?”

Rapamycin may be worth discussing if you want a proactive, science-based approach to your dog’s aging. But it should be considered alongside weight, nutrition, exercise, dental health, early disease detection, and your dog’s individual risks.

This is where experienced veterinary guidance matters.

How to get veterinarian-guided rapamycin

Helping Pets Live Longer offers two ways to begin.

If you already work with a veterinarian

Your veterinarian can evaluate your dog and send HPLL a prescription if they believe rapamycin is appropriate.

Explore prescription rapamycin for cats

Explore prescription rapamycin for dogs

If you want Dr. Kevin to evaluate your pet:

Join our Pet Longevity Protocol. Dr. Kevin will review your pet’s:

• Medical records
• Breed and age-related risks
• Laboratory results
• Current medications and supplements
• Diet and metabolic health
• Early-detection needs
• Possible fit for rapamycin or other longevity medications

You will receive a clear, written plan explaining what matters most, what to do now, and what to monitor next.

Explore our Pet Longevity Protocol here.

The bottom line

Rapamycin is one of the most promising drugs in longevity research. It affects a major cell pathway involved in growth, repair, metabolism, and aging.

The science supports serious interest—but not exaggerated promises.

For the right cat or dog, rapamycin may be one useful part of a larger medical plan. The strongest longevity strategy also includes healthy weight, good nutrition, exercise, dental care, early detection, and ongoing veterinary oversight.

Longevity is not one miracle pill. It is a series of better decisions made earlier—with a veterinarian who knows how to connect them.

Medically reviewed by Kevin Toman, DVM. This article is for education only and does not replace an individual veterinary examination, diagnosis, or treatment plan.

Scientific references

1. Urfer SR, et al. A randomized controlled trial of short-term rapamycin treatment in 24 middle-aged companion dogs. GeroScience. 2017.
2. Kaplan JL, et al. Delayed-release rapamycin in cats with subclinical hypertrophic cardiomyopathy: the RAPACAT trial. Journal of the American Veterinary Medical Association. 2023.
3. Harrison DE, et al. Rapamycin given later in life extends lifespan in genetically diverse mice. Nature. 2009.
4. Kennedy BK, Lamming DW. The mechanistic target of rapamycin and its role in metabolism and aging. Cell Metabolism. 2016.
5. Dog Aging Project. Test of Rapamycin in Aging Dogs clinical trial.